Chu Chieh Hsia
Affiliation: Food and Drug Administration
- Quantification of hepatitis B virus genomes and infectivity in human serum samplesChu Chieh Hsia
Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Bethesda, Maryland, USA
Transfusion 46:1829-35. 2006....
- Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samplesChu Chieh Hsia
Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892, USA
Biochem Biophys Res Commun 356:1017-23. 2007..Our data represent a proof-of-concept for the possible use of highly sensitive multiplex microarray assay to screen and confirm the presence of these viruses in blood donors and patients...
- Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionRobin Biswas
Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland, USA
Transfusion 43:788-98. 2003..A study was designed to estimate relative analytic sensitivity and window-period (WP) closure and to project incremental yield of newer HBsAg tests, pooled-sample NAT, and single-sample NAT, compared to currently licensed HBsAg tests...
- Truncated hepatitis C virus core protein encoded in hepatocellular carcinomasRin Yamaguchi
Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, MD 20852, USA
Int J Mol Med 14:1097-100. 2004....